Chenodal
Payments companies reported to CMS as associated with Chenodal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Chenodal, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Chenodal
These are the largest totals companies reported as associated with Chenodal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Steiner | Madison, WI | Clinical Genetics (M.D.) | $25,575.85 |
| Ernst Schaefer | Boston, MA | Endocrinology, Diabetes & Metabolism | $13,546.30 |
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $13,306.78 |
| Peter Kowey | Wynnewood, PA | Cardiovascular Disease | $5,325.00 |
| Gerald Raymond | Baltimore, MD | Neurology With Special Qualifications In Child Neurology | $2,400.00 |
| Joseph Quinn | Portland, OR | Neurology (Psychiatry & Neurology) | $1,200.00 |
| David Marble | Show Low, AZ | Emergency Medicine | $145.49 |
| Paul Hillman | Houston, TX | Clinical Genetics (M.D.) | $141.91 |
| Eva Morava-Kozicz | Rochester, MN | Clinical Genetics (M.D.) | $141.91 |
| Amy Kritzer | Boston, MA | Clinical Genetics (M.D.) | $141.91 |
Prescribed Chenodal?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.